Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-22-008729

Options or other derivatives

  • Director acquired 36,880 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Martin Anne-Marie Director 2022-03-01 Grant or award · Stock Option (Right to Buy) +36,880 36,880 D
Loading xslF345X03/doc4.xml…